Anne‐Joy M. de Graan

Author

Erasmus MC

Also Known As

A. M. de Graan, A.M. De Graan, Anne-Joy M de Graan, Anne-Joy M. de Graan, Anne‐Joy M. de Graan

Publications

493

Citations

H-Index

Concepts

All Affiliations

Erasmus MC Erasmus MC Cancer Institute St. Jude Children's Research Hospital Uppsala University Erasmus University Rotterdam

About

Anne‐Joy M. de Graan is an author at Erasmus MC specializing in analytical chemistry, mass spectrometry, and drug analysis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	49
2	Biochemistry	2	2	49
3	Pharmacology	2	2	49
4	Mass Spectrometry	2	2	49
5	Clinical Chemistry	1	1	35

Anne‐Joy M. de Graan

Publications

443

Citations

H-Index

Page 1

	Year	Citations
<i>CYP3A4*22</i> Genotype and Systemic Exposure Affect Paclitaxel-Induced Neurotoxicity Anne‐Joy M. de Graan, Laure Elens, Jason A. Sprowl, Clinical Cancer Research	2013	100
Influence of Polymorphic OATP1B-Type Carriers on the Disposition of Docetaxel Anne‐Joy M. de Graan, Cynthia S. Lancaster, Amanda Obaidat, Clinical Cancer Research	2012	91
Dextromethorphan As a Phenotyping Test to Predict Endoxifen Exposure in Patients on Tamoxifen Treatment Anne‐Joy M. de Graan, Sebastiaan F. Teunissen, Filip De Vos, Journal of Clinical Oncology	2011	55
Impact of POR*28 on the clinical pharmacokinetics of CYP3A phenotyping probes midazolam and erythromycin Laure Elens, Annemieke J.M. Nieuweboer, Stephen Clarke, Pharmacogenetics and Genomics	2013	42
Influence of Smoking on the Pharmacokinetics and Toxicity Profiles of Taxane Therapy Anne‐Joy M. de Graan, Walter J. Loos, Lena E. Friberg, Clinical Cancer Research	2012	38
Quantification of cabazitaxel in human plasma by liquid chromatography/triple-quadrupole mass spectrometry: A practical solution for non-specific binding Peter de Bruijn, Anne‐Joy M. de Graan, Annemieke J.M. Nieuweboer, Journal of Pharmaceutical and Biomedical Analysis BiochemistryGas ChromatographyMedicinePractical SolutionBioanalysis	2011	35
A Pharmacogenetic Predictive Model for Paclitaxel Clearance Based on the DMET Platform Anne‐Joy M. de Graan, Laure Elens, Marcel Smid, Clinical Cancer Research	2013	22
4β‐hydroxycholesterol as an endogenous CYP3A marker in cancer patients treated with taxanes Anne‐Joy M. de Graan, Alex Sparreboom, Peter de Bruijn, British Journal of Clinical Pharmacology	2015	18
Predicting Paclitaxel-Induced Neutropenia Using the DMET Platform Annemieke J.M. Nieuweboer, Marcel Smid, Anne‐Joy M. de Graan, Pharmacogenomics	2015	16
Simultaneous quantification of dextromethorphan and its metabolites dextrorphan, 3-methoxymorphinan and 3-hydroxymorphinan in human plasma by ultra performance liquid chromatography/tandem triple-quadrupole mass spectrometry Walter J. Loos, Anne‐Joy M. de Graan, Peter de Bruijn, Journal of Pharmaceutical and Biomedical Analysis BiochemistryMedicineTriple-quadrupole Mass SpectrometryMass SpectrometryMetabolomic Profiling	2010	14

Page 1